Literature DB >> 10837176

Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury.

A Takala1, J Lähdevirta, S E Jansson, O Vapalahti, A Orpana, S L Karonen, H Repo.   

Abstract

Systemic inflammation is common in patients with nephropathia epidemica (NE), a European form of hemorrhagic fever. Markers of inflammation were studied in a patient with NE with respiratory insufficiency (patient 1), 18 other patients with NE, and 13 patients with a viral infectious disease other than NE. Neutrophil and monocyte CD11b expression levels, determined by flow cytometry; soluble interleukin (IL)-2 receptor (sIL-2R), IL-6, and IL-8 concentrations, determined by means of Immulite; and soluble E-selectin, determined by ELISA, were higher in patients with NE than in healthy subjects. The findings were not specific for NE and did not correlate with serum creatinine levels, but the findings correlated inversely with mean arterial pressure (sIL-2R and monocyte CD11b expression) and minimum platelet count (sIL-2R, IL-6, neutrophil, and monocyte CD11b expression). Monocyte CD11b expression in patient 1 was extremely high, suggesting that monocytes may contribute to development of lung injury. Severity of inflammation in patients with NE is related to hypotension and platelet consumption but not to renal injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837176     DOI: 10.1086/315522

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations.

Authors:  Tuula K Outinen; Satu M Mäkelä; Ilpo O Ala-Houhala; Heini Sa Huhtala; Mikko Hurme; Antti S Paakkala; Ilkka H Pörsti; Jaana T Syrjänen; Jukka T Mustonen
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

2.  Low levels of serum vitronectin associated with clinical phases in patients with hemorrhagic fever with renal syndrome.

Authors:  Zhengwen Liu; Qunying Han; Lei Zhang; Qianzi Zhao; Jinghong Chen; Sai Lou
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

3.  Upregulation of IFN-γ and IL-12 is associated with a milder form of hantavirus hemorrhagic fever with renal syndrome.

Authors:  S F Khaiboullina; E V Martynova; Z L Khamidullina; E V Lapteva; I V Nikolaeva; V V Anokhin; V C Lombardi; A A Rizvanov
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-19       Impact factor: 3.267

4.  Thrombocytopenia and acute renal failure in Puumala hantavirus infections.

Authors:  Franz Maximilian Rasche; Boris Uhel; Detlev H Krüger; Wolfram Karges; David Czock; Walter Hampl; Frieder Keller; Helga Meisel; Lutz von Müller
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

5.  Endothelial activation and repair during hantavirus infection: association with disease outcome.

Authors:  Anne-Marie Connolly-Andersen; Therese Thunberg; Clas Ahlm
Journal:  Open Forum Infect Dis       Date:  2014-05-29       Impact factor: 3.835

6.  The fundamental role of endothelial cells in hantavirus pathogenesis.

Authors:  Jussi Hepojoki; Antti Vaheri; Tomas Strandin
Journal:  Front Microbiol       Date:  2014-12-22       Impact factor: 5.640

7.  Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections.

Authors:  Meiliang Wang; Jiuping Wang; Tianping Wang; Jing Li; Ling Hui; Xiaoqin Ha
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

Review 8.  Immunological mechanisms mediating hantavirus persistence in rodent reservoirs.

Authors:  Judith D Easterbrook; Sabra L Klein
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

9.  Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.

Authors:  P Osterlund; A Orpana; I Elomaa; H Repo; H Joensuu
Journal:  Br J Cancer       Date:  2002-09-09       Impact factor: 7.640

10.  Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.

Authors:  Janice M Rusnak; William R Byrne; Kyung N Chung; Paul H Gibbs; Theodore T Kim; Ellen F Boudreau; Thomas Cosgriff; Philip Pittman; Katie Y Kim; Marianne S Erlichman; David F Rezvani; John W Huggins
Journal:  Antiviral Res       Date:  2008-10-31       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.